CSIMarket
 


La Jolla Pharmaceutical Company  (LJPC)
Other Ticker:  
 

La Jolla Pharmaceutical's Leverage Ratio

LJPC's quarterly Leverage Ratio and Total Liabilities, Equity growth


In II Quarter 2022 La Jolla Pharmaceutical had stockholder deficit.

Within Biotechnology & Pharmaceuticals industry La Jolla Pharmaceutical Company achieved the lowest Leverage Ratio in the second quarter 2022. While total ranking remained the same in the second quarter 2022 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are LJPC Customers?
What are LJPC´s Total Liabilities?


LJPC Leverage Ratio (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change 0.93 % 3.19 % -1.65 % 1.99 % -8.39 %
Leverage Ratio MRQ - - - - -
LJPC's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Total Liabilities Change 1.18 % 5.97 % -6.57 % 0.75 % 3.45 %



Leverage Ratio second quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
La Jolla Pharmaceutical's Equity $ -69 Millions Visit LJPC's Balance sheet
La Jolla Pharmaceutical's Total Liabilities $ 169 Millions Visit LJPC's Balance sheet
Source of LJPC's Sales Visit LJPC's Sales by Geography


Cumulative La Jolla Pharmaceutical's Leverage Ratio

LJPC's Leverage Ratio for the trailling 12 Months

LJPC Leverage Ratio

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 0.93 % 3.19 % -1.65 % 1.99 % -8.39 %
Leverage Ratio TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth 1.18 % 5.97 % -6.57 % 0.75 % 3.45 %


On the trailing twelve months basis During the 12 months period ending II Quarter 2022 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry LJPC recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Leverage Ratio?
Who are LJPC Customers?
What are LJPC´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Leverage Ratio in the quarter ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage RatioJun 30 2022 MRQ Total LiabilitiesJun 30 2022 MRQ Equity

Date modified: 2023-03-22T19:11:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com